LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

ReShape Lifesciences Inc

Uždarymo kaina

3.35 13.95

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.35

Max

3.35

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-12

ReShape Lifesciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-21 23:45; UTC

Uždarbis

Li Ning's 1st Half Profit Drops on Higher Tax Expense

2025-08-21 21:29; UTC

Uždarbis

Intuit 4Q Sales Jump 20%, Expects Slower Growth Ahead -- Update

2025-08-21 21:12; UTC

Uždarbis

Workday 2Q Profit Rises With Jump in Revenue

2025-08-21 23:47; UTC

Rinkos pokalbiai

Nikkei May Trade in Range Amid Caution Over U.S. Econ Outlook -- Market Talk

2025-08-21 23:30; UTC

Uždarbis

Li Ning's 1H Profit Drops on Higher Tax Expense

2025-08-21 23:22; UTC

Uždarbis

Resolute Mining Reiterates 2025 Output, Cost, Capex Guidance

2025-08-21 23:22; UTC

Uždarbis

Resolute Mining Cash, Bullion Worth A$158.7 Million at June 30

2025-08-21 23:21; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-21 23:21; UTC

Rinkos pokalbiai

Intuit Sees Early Traction with AI Agents -- Market Talk

2025-08-21 23:21; UTC

Uždarbis

Resolute Mining Net Cash A$109.9 Million at June 30

2025-08-21 23:20; UTC

Uždarbis

Resolute Mining 1H Revenue A$447.5 Million, Up 31% On-Year

2025-08-21 23:20; UTC

Uždarbis

Resolute Mining 1H Ebitda A$211.1 Million, Up 81% On-Year

2025-08-21 23:20; UTC

Uždarbis

Resolute Mining Won't Pay an Interim Dividend

2025-08-21 23:19; UTC

Uždarbis

Resolute Mining 1H Net Profit A$58.8 Million Vs A$20.9 Million Year Earlier

2025-08-21 22:37; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-21 22:36; UTC

Rinkos pokalbiai

Peter Warren Automotive Moving Into Higher Gear -- Market Talk

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

TSMC Executives Considered Giving Back Chips Act Funds if Government Asked for Equity, Sources Say -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

How Trump Will Decide Which Chips Act Companies Must Give Up Equity -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Commerce Secretary Lutnick Previously Indicated Government May Hold Equity in Semiconductor Companies Other Than Intel -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Administration Might Take Equity in Smaller Companies Receiving Funds Under the Act, Official Says -- WSJ

2025-08-21 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Trump Administration Considers Taking Stakes in Companies Receiving Chips Act Money, Source Says -- WSJ

2025-08-21 22:33; UTC

Rinkos pokalbiai

Australia Shares Set to Retreat From Record -- Market Talk

2025-08-21 22:20; UTC

Uždarbis

Regis Resources Cash, Bullion A$517.2 Million at June 30

2025-08-21 22:19; UTC

Uždarbis

Regis Resources FY Ebitda A$780.1 Million Vs A$296.9 Million Year Prior

2025-08-21 22:18; UTC

Uždarbis

Regis Resources FY Revenue A$1.65 Billion, Up 30% On-Year

2025-08-21 22:18; UTC

Uždarbis

Regis Resources to Pay Final Dividend of 5 Australian Cents/Share

2025-08-21 22:17; UTC

Uždarbis

Regis Resources Net Profit A$254.4 Million Vs A$186.0 Million Loss Year Prior

2025-08-21 22:14; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-08-21 22:14; UTC

Rinkos pokalbiai
Uždarbis

Brambles' Stock Surge Suggests Comfort With Guidance -- Market Talk

2025-08-21 21:43; UTC

Karštos akcijos

Intuit, Ross Stores, Workday: Stocks to Watch Afterhours -- WSJ

Akcijų palyginimas

Kainos pokytis

ReShape Lifesciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

$